Your browser doesn't support javascript.
loading
New Mechanisms of mTOR Pathway Activation in KIT-mutant Malignant GISTs.
Lasota, Jerzy; Kowalik, Artur; Felisiak-Golabek, Anna; Zieba, Sebastian; Wang, Zeng-Feng; Miettinen, Markku.
Afiliação
  • Lasota J; Laboratory of Pathology, National Cancer Institute, Bethesda, MD.
  • Kowalik A; Department of Molecular Diagnostics, Holycross Cancer Center, Kielce, Poland.
  • Felisiak-Golabek A; Laboratory of Pathology, National Cancer Institute, Bethesda, MD.
  • Zieba S; Department of Molecular Diagnostics, Holycross Cancer Center, Kielce, Poland.
  • Wang ZF; Laboratory of Pathology, National Cancer Institute, Bethesda, MD.
  • Miettinen M; Laboratory of Pathology, National Cancer Institute, Bethesda, MD.
Appl Immunohistochem Mol Morphol ; 27(1): 54-58, 2019 01.
Article em En | MEDLINE | ID: mdl-28777148
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumores do Estroma Gastrointestinal / Classe I de Fosfatidilinositol 3-Quinases / Serina-Treonina Quinases TOR / Fibroblastos / Proteína 2 do Complexo Esclerose Tuberosa / Neoplasias Gastrointestinais / Mutação Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Appl Immunohistochem Mol Morphol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumores do Estroma Gastrointestinal / Classe I de Fosfatidilinositol 3-Quinases / Serina-Treonina Quinases TOR / Fibroblastos / Proteína 2 do Complexo Esclerose Tuberosa / Neoplasias Gastrointestinais / Mutação Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Appl Immunohistochem Mol Morphol Ano de publicação: 2019 Tipo de documento: Article